Alla Arzumanyan

Temple University

Alla Arzumanyan received her Ph.D. in Biotechnology from Yerevan State University, Armenia in 2003. She pursued postdoctoral training at Temple University and Thomas Jefferson University in Philadelphia, USA. In 2008 she joined Dr. Feitelson’s group and is currently a Research Associate Professor. She has worked on the pathogenesis of hepatitis B and has developed an artificial immune system to diagnose serious human pathogens. She is Chief Development Officer for SFA Therapeutics and has developed a novel microbiome-based treatment for plaque psoriasis. She has co-authored 17 original papers and three book chapters, and has presented 17 posters/invited talks.

Alla Arzumanyan